Bispecific antibodies (bsAbs) directed against PD-1/PD-L1 and CTLA-4; a mini review
{{output}}
Novel approaches to tumor immunotherapy include adoptive cell immunotherapy, immune checkpoint inhibitors (ICIs), and bispecific antibodies (bsABs). bsABs are members of the antibody family that have the ability to distinguish between two distinct antigens or ... ...